Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Ao Y, Leng C, Chen J, Luo K, Shao L, Liu Q, Li Q, Liu H, Xi M, Zhang X, Yang H, Fu J

Open source

DOI
10.1245/s10434-026-20342-8
Published
2026 Aug 17
Container
Annals of surgical oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1245/s10434-026-20342-8,
  title = {Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.},
  author = {Ao Y and Leng C and Chen J and Luo K and Shao L and Liu Q and Li Q and Liu H and Xi M and Zhang X and Yang H and Fu J},
  year = {2026},
  journal = {Annals of surgical oncology},
  doi = {10.1245/s10434-026-20342-8},
  url = {https://doi.org/10.1245/s10434-026-20342-8}
}

RIS

TY  - JOUR
TI  - Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
AU  - Ao Y
AU  - Leng C
AU  - Chen J
AU  - Luo K
AU  - Shao L
AU  - Liu Q
AU  - Li Q
AU  - Liu H
AU  - Xi M
AU  - Zhang X
AU  - Yang H
AU  - Fu J
PY  - 2026
JO  - Annals of surgical oncology
DO  - 10.1245/s10434-026-20342-8
UR  - https://doi.org/10.1245/s10434-026-20342-8
ER  - 

APA

Y, A., C, L., J, C., K, L., L, S., Q, L., Q, L., H, L., M, X., X, Z., H, Y., & J, F. (2026). Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-20342-8

Source records